Clearmind Medicine (CSE: CMND, FSE: CWY) develops novel psychedelic medicines to solve widespread, yet under-served, health problems. With a strong medical management team and IP-protection, we can better the lives of millions. With a clear focus on alcohol abuse and binge drinking, Clearmind's first drug candidate addresses very common (and costly) afflictions which to date, have limited solutions.